Toronto Memory Program

11/18/2025

On November 12, 2025, Dr. Sharon Cohen—Founder and Medical Director of Toronto Memory Program—joined the Alzheimer Society of Huron-Perth to deliver her talk, “A New Era: 2025 Update on Diagnosis and Treatment of Alzheimer’s Disease.” Dr. Cohen provided a comprehensive update on emerging research that is reshaping the dementia treatment landscape in Canada.

In her presentation, she discussed the progression and risk factors for dementia, promising new treatments currently in Phase III clinical trials, the impact of brain-healthy lifestyle choices, and the critical importance of participation in clinical trials.

Alzheimer Society Huron Perth - 2025 Dementia Research Night. On November 12, 2025, Dr. Sharon Cohen, founder and Medical Director of the Toronto Memory Prog...

11/13/2025

Today, our Medical Director and Behavioural Neurologist, Dr. Sharon Cohen, had the pleasure of presenting to the wonderful community at Extended Learning Opportunities (ELO) in Erin, Ontario — a volunteer-run lifelong learning group dedicated to bringing educational events to their community.

Dr. Cohen delivered A New Era: 2025 Update on Alzheimer’s Diagnosis & Treatment — a timely and inspiring session highlighting how far we’ve come in understanding, diagnosing, and treating Alzheimer’s disease.

With Canada’s first disease-slowing treatment for Alzheimer’s now approved, this truly is a historic moment. More individuals are seeking early assessment, new diagnostic tools (including blood tests) are becoming available, and community education has never been more important.

We loved connecting with this thoughtful, engaged audience and having the chance to answer their questions.

A meaningful day of learning, hope, and progress — and we’re grateful to be part of it.

11/04/2025

Alzheimer’s disease drug Leqembi has received approval in Canada for treating early-stage Alzheimer’s disease. Our Medical Director, Dr. Sharon Cohen, who was involved in the Eisai clinical trials, spoke with Being Patient about what this milestone means for Canadian patients — including next steps for access, coverage, and ongoing data collection to confirm real-world benefits.

Alzheimer’s drug Leqembi will soon be available in Canada, but it isn’t clear whether it will be covered by public health insurance.

10/31/2025

No tricks, just treats - and maybe a few clinical trials! 🎃👻

10/30/2025

Dr. Sharon Cohen, Medical Director of Toronto Memory Program, joined Fight Back with Libby Znaimer to discuss lecanemab, a new Alzheimer's disease drug just approved by Health Canada. Dr. Cohen was involved in the clinical trials of the drug as a Principal Investigator. To catch the full interview, visit zoomerradio.ca/podcasts.Iifator

10/28/2025

Toronto Memory Program Medical Director and Neurologist Dr. Sharon Cohen discusses on CTV News the Alzheimer’s drug that targets the underlying cause of the disease and key findings from the clinical trials.

Neurologist Dr. Sharon Cohen speaks on the Alzheimer's drug that targets the underlining cause of the disease and what was discovered during clinical trials....

10/27/2025

Health Canada has officially approved lecanemab (Leqembi) — the FIRST treatment in Canada proven to slow the progression of early Alzheimer’s disease!

At Toronto Memory Program, we are incredibly proud of our clinical trial participants, study partners, and dedicated research team who helped make this milestone possible. Their commitment and courage have directly contributed to bringing this treatment to Canadians.

This is a day of hope, progress, and renewed energy for all those affected by Alzheimer’s disease.

10/21/2025

New here? Welcome to Toronto Memory Program!

We’re advancing Alzheimer’s disease prevention and treatment through compassionate care, innovative research, and education.

Who We Are:
Based in North York, our 60+ staff specialize in Alzheimer’s disease and related cognitive disorders—bridging clinical care and research to bring new treatments forward.

Our Mission:
To educate the public on early detection, promote participation in clinical trials, reduce barriers to diagnosis through free testing, and empower patients and families through education and access.

Meet Our Director:
Dr. Sharon Cohen, Cognitive & Behavioural Neurologist, Director, and global leader in Alzheimer’s disease clinical research.

Our Research Program:
As Canada’s largest Alzheimer’s disease clinical trial site, we’ve conducted more than 185 studies across all phases.

Benefits of Participation:
No-cost study care, regular health monitoring, and access to innovative therapies—helping move science forward for future generations.

Get Involved:
We are all impacted by Alzheimer’s disease. Join us, share our mission, and help move research forward.

10/20/2025

Feeling Stressed or Anxious? Try These Simple Reset Techniques

Stress is a normal part of life—but when it sticks around, it can drain your energy, mood, and health. Try adding these small habits to your day:

• Deep Breathing – Inhale 4 sec, hold 4, exhale 4. Repeat. Slows your heart rate & calms your mind.
• Move Your Body – A 30-minute walk or even 5-minute movement breaks can cut stress fast.
• Mindfulness – Take a quiet moment to breathe and bring your focus back to right now.
• Muscle Relaxation – Tense, hold, and release each muscle group to release stored tension.
• Visualization – Close your eyes and picture a calming place—your brain responds like it’s real.
• Yoga or Stretching – Combines breath + movement to reset your nervous system.
• Bonus therapies you can explore: aromatherapy, art, massage, music, warm baths, or cold showers.

Prevention Tip: Build a simple daily routine, get outside, cut back on constant media, and stay connected with people who make you feel good.

If stress starts affecting your sleep, mood, or daily life—reach out to a healthcare provider. You're not meant to carry it alone.

10/17/2025

Your brain needs the right fuel to function at its best.

Regular blood work is an important part of maintaining brain health — especially as we age.

Low levels of vitamin B12 and other nutrients can affect memory, mood, and concentration, and in some cases, mimic symptoms of cognitive decline.

✅ Stay proactive:
- Ask your healthcare provider about checking your B12 and other key labs.
- Address deficiencies early to support overall cognitive health.

10/14/2025

With the leaves changing across Canada, it’s a great time to step outside and enjoy nature. Spending time outdoors isn’t just refreshing — it supports your mental health too:

• Reduces stress and anxiety
• Boosts mood and focus
• Encourages physical activity and mindfulness

Here are some easy-rated trails around the GTA that are perfect for a fall walk:
• Evergreen Brick Works Trail (Toronto) – Short, scenic loop with great city views
• High Park Trails (Toronto) – Easy paths surrounded by fall colour
• Rouge National Urban Park (Scarborough) – Gentle riverside and forest trails
• Rattray Marsh Conservation Area (Mississauga) – Boardwalks and lake views
• Hilton Falls Trail (Milton) – Easy route with a beautiful waterfall
• Kortright Centre for Conservation (Vaughan) – Well-marked trails through maple forest

Take a break, get some fresh air, and enjoy the season while it lasts! 🍁

10/09/2025

Dr. Sharon Cohen, Medical Director of Toronto Memory Program, joins Russo Partners’ Conversations That Matter podcast for “Early Detection Matters: Insights into Alzheimer’s Treatments and Caregiving.”

In this conversation with host Solomon Wilcots and guest Muffy Walker, Dr. Cohen discusses how earlier, more accurate diagnosis can change the trajectory of Alzheimer’s care, and shares practical strategies for supporting patients and caregivers alike.

Learn about:

• How clinicians assess memory changes and use biomarkers in diagnosis
• Where new Alzheimer’s therapies fit into care plans
• Real-world tips to ease caregiver burden and promote brain health

Watch the full episode:

Dr. Sharon Cohen, Medical Director at Toronto Memory Program, and author Muffy Walker, join host Solomon Wilcots for a candid, practical conversation about A...